Australia’s Medical Research Commercialisation Fund invests in Auspherix
Auspherix Pty Ltd said Thursday it has secured another AU$1 million (US$878,215) in a series A financing from Australia’s Medical Research Commercialisation Fund. Auspherix, of Sydney, is an early stage anti-infectives company developing antibiotics to treat resistant bacterial disease.
23 October 2014•4 mins read
